As a result of attending this session, participants will be able to:
Identify patients who meet referral criteria for BRCA1/2 genetic testing
List current screening recommendations for BRCA1/2 carriers
Discuss risk-reducing strategies for preventing BRCA-associated breast and ovarian/fallopian tube cancers